|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SP, Alt AL, Weight CJ, et al:
Independent validation of the 2010 American Joint Committee on
Cancer TNM classification for renal cell carcinoma: results from a
large, single institution cohort. J Urol. 185:2035–2039. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ljungberg B, Cowan NC, Hanbury DC, et al:
European Association of Urology Guideline Group: EAU guidelines on
renal cell carcinoma: the 2010 update. Eur Urol. 58:398–406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grignon DJ and Che M: Clear cell renal
cell carcinoma. Clin Lab Med. 25:305–316. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gudbjartsson T, Hardarson S, Petursdottir
V, et al: Histological subtyping and nuclear grading of renal cell
carcinoma and their implications for survival: a retrospective
nation-wide study of 629 patients. Eur Urol. 48:593–600. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng L, Zhang S, MacLennan GT,
Lopez-Beltran A and Montironi R: Molecular and cytogenetic insights
into the pathogenesis, classification, differential diagnosis, and
prognosis of renal epithelial neoplasms. Hum Pathol. 40:10–29.
2009. View Article : Google Scholar
|
|
7
|
Subramani D and Alahari SK:
Integrin-mediated function of Rab GTPases in cancer progression.
Mol Cancer. 9:3122010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanos B and Rodriguez-Boulan E: The
epithelial polarity program: machineries involved and their
hijacking by cancer. Oncogene. 27:6939–6957. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nam KT, Lee HJ, Smith JJ, et al: Loss of
Rab25 promotes the development of intestinal neoplasia in mice and
is associated with human colorectal adenocarcinomas. J Clin Invest.
120:840–849. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tong M, Chan KW, Bao JY, et al: Rab25 is a
tumor suppressor gene with antiangiogenic and anti-invasive
activities in esophageal squamous cell carcinoma. Cancer Res.
72:6024–6035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Agarwal R, Jurisica I, Mills GB and Cheng
KW: The emerging role of the RAB25 small GTPase in cancer. Traffic.
10:1561–1568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng KW, Lahad JP, Kuo WL, et al: The
RAB25 small GTPase determines aggressiveness of ovarian and breast
cancers. Nat Med. 10:1251–1256. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Wei J, Lu J, et al:
Overexpression of Rab25 contributes to metastasis of bladder cancer
through induction of epithelial-mesenchymal transition and
activation of Akt/GSK-3β/Snail signaling. Carcinogenesis.
34:2401–2408. 2013.PubMed/NCBI
|
|
14
|
Greene FL, Gospodarowicz MK and Wittekend
C: American Joint Committee on Cancer (AJCC) Staging Manual. 7th
edition. Springer; Philadelphia, USA: pp. 147–149. 2009
|
|
15
|
Schwartz SL, Cao C, Pylypenko O, Rak A and
Wandinger-Ness A: Rab GTPases at a glance. J Cell Sci.
120:3905–3910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng KW, Lahad JP, Gray JW and Mills GB:
Emerging role of RAB GTPases in cancer and human disease. Cancer
Res. 65:2516–2519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caswell PT, Spence HJ, Parsons M, et al:
Rab25 associates with alpha5beta1 integrin to promote invasive
migration in 3D microenvironments. Dev Cell. 13:496–510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dozynkiewicz MA, Jamieson NB, Macpherson
I, et al: Rab25 and CLIC3 collaborate to promote integrin recycling
from late endosomes/lysosomes and drive cancer progression. Dev
Cell. 22:131–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin YX, Shen F, Pei H, et al: Increased
expression of Rab25 in breast cancer correlates with lymphatic
metastasis. Tumour Biol. 33:1581–1587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng JM, Ding M, Aribi A, Shah P and Rao
K: Loss of RAB25 expression in breast cancer. Int J Cancer.
118:2957–2964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldenring JR and Nam KT: Rab25 as a
tumour suppressor in colon carcinogenesis. Br J Cancer. 104:33–36.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tringali C, Lupo B, Silvestri I, et al:
The plasma membrane sialidase NEU3 regulates the malignancy of
renal carcinoma cells by controlling β1 integrin internalization
and recycling. J Biol Chem. 51:42835–42845. 2012.PubMed/NCBI
|
